CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...
PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...
Medpage Today on MSN7d
Use of GLP-1 Drugs for Obesity Linked to Lower Risk of GlaucomaUse of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...
In a world inundated with weight loss products and miracle supplements, it can be overwhelming to determine what truly works. Enter LipoVive, a groundbreaking supplement that has captured the ...
However, Zepbound is proven to be more effective for weight loss than Wegovy since it targets two hormones, GLP-1 and GIP. Total Zepbound sales were $4.93 billion in 2024 for Lilly. Zepbound had a ...
Wendy Barnes is president and CEO of GoodRx. Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback